Haywood analyst Gianluca Tucci reiterated a Buy rating on Kits Eyecare yesterday and set a price target of C$21.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Gianluca Tucci has given his Buy rating due to a combination of factors including Kits Eyecare’s impressive financial performance and promising market trends. The company reported strong Q2/25 results with revenue and adjusted EBITDA aligning with preannouncements, and a gross margin that exceeded expectations. Notably, Kits Eyecare achieved a remarkable 31% organic growth for the fourth consecutive quarter, highlighting its robust operational capabilities.
Additionally, the company’s management has provided optimistic guidance for Q3/25, with revenue and EBITDA margin projections surpassing street consensus. This positive outlook is supported by a significant increase in glasses sales and a growing base of returning customers. Furthermore, the eyewear market is undergoing a substantial shift towards e-commerce, presenting a vast opportunity for growth, particularly in the digital sales of prescription eyeglasses. These factors collectively underpin Tucci’s confidence in the stock’s potential, leading to the Buy recommendation.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a C$19.00 price target.